Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zynerba Pharma CS (NQ: ZYNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zynerba Pharma CS < Previous 1 2 3 4 5 6 7 8 9 10 Next > Cannabis Stock Movers For August 3, 2023 August 03, 2023 Via Benzinga Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting July 25, 2023 Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDT From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday March 08, 2023 On Wednesday, 116 companies set new 52-week lows. Via Benzinga Marijuana Stock Movers For August 2, 2023 August 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 19, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 18, 2023 July 18, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 14, 2023 July 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session July 13, 2023 Via Benzinga Marijuana Stock Movers For July 12, 2023 July 12, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 11, 2023 July 11, 2023 Via Benzinga Cannabis Stock Movers For July 10, 2023 July 10, 2023 Via Benzinga Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting June 28, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket June 28, 2023 Gainers Theriva Biologics, Inc. (NYSE: TOVX) shares surged 76.4% to $1.46 in pre-market trading after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for... Via Benzinga Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket June 27, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 27, 2023 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning! Via InvestorPlace Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference June 20, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting June 13, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting May 23, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details May 15, 2023 Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) released financial results for the first quarter ended March 31, 2023, revealing research and development expenses were $7.1 million for the first quarter... Via Benzinga Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights May 15, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday April 26, 2023 On Wednesday, 345 companies set new 52-week lows. Via Benzinga Zynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg Conference April 12, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference April 05, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss? March 28, 2023 Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) released financial results for the fourth quarter and full year ended December 31, 2022, revealing research and development expenses were $21.1 million for... Via Benzinga Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights March 28, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Silicon Valley Bank Failure Is Just The Tip Of Financial Iceberg, Could Affect Unexpected Industries March 14, 2023 Last week the US economy got clobbered by the biggest banking collapse since 2008 when the parent of Silicon Valley Bank, SVB Financial Group (NASDAQ: SIVB) failed to raise enough capital to continue. Via Benzinga Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley Bank March 13, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday March 10, 2023 On Friday, 497 companies set new 52-week lows. Via Benzinga Zynerba Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference March 07, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session March 06, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.